Key result
Surgical tricuspid repair remains safe and feasible for tricuspid regurgitation, anchored by annuloplasty.
Why the study?
While percutaneous therapies for tricuspid regurgitation continue to advance, anatomic constraints may necessitate consideration of surgery in some patients.
Surgical tricuspid valve repair remains a durable option for severe TR, with annuloplasty as the cornerstone, while transcatheter therapies are evolving as complementary options requiring a multidisciplinary heart team approach.
Answers are grounded in this paper and cite their sources.
May support surgical repair for severe TR; leaves open comparative trials versus percutaneous options.
Background: Tricuspid valve surgery is indicated for severe symptomatic tricuspid valve regurgitation (TR) when performed concomitant to another cardiac operation. While percutaneous therapies for TR continue to advance, anatomic constraints may necessitate consideration of surgery in some patients. Methods: Herein, we provide a contemporary review of surgical techniques used to treat TR, which can serve as a complement to existing and emerging tricuspid valve treatment therapies. Results: We performed a literature review on established surgical tricuspid repair techniques. Conclusions: Surgical repair of the tricuspid valve is safe and feasible. While annuloplasty remains the cornerstone operative strategy, leaflet and sub-valvular techniques serve as adjuncts to help successful repair. The therapeutic paradigm for TR continues to evolve.
No takes yet. Share an insight, caveat, or question.
Vasanthan et al. (2026) conducted a review in Tricuspid valve regurgitation. Surgical tricuspid valve repair was evaluated. Surgical repair of the tricuspid valve is a safe and feasible treatment for primary and secondary tricuspid regurgitation, with annuloplasty remaining the cornerstone operative strategy.
Synapse has enriched 10 related papers. Consider them for comparative context: